Epidemiology of adverse drug reactions in Europe: a review of recent observational studies
about
Pharmacogenetics and Predictive Testing of Drug Hypersensitivity ReactionsSafety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative StudiesA systematic review of observational studies evaluating costs of adverse drug reactionsIncidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatientsAdverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010-2013).Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients.The key role of clinical and community health nurses in pharmacovigilance.Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches.Testing an explanatory model of nurses' intention to report adverse drug reactions in hospital settings.Medication reconciliation as a medication safety initiative in Ethiopia: a study protocol.Accuracy of an automated knowledge base for identifying drug adverse reactions.Is polypharmacy an independent risk factor for adverse outcomes after an emergency department visit?Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand.Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.Drug-Related Inadvertent Deaths in a University Hospital--A Declining Trend.Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models.Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review.Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug Metabolites.Severe ketorolac-induced asthma diagnosed by chest computed tomography.Indicators related to the rational use of medicines and its associated factors.ADReCS-Target: target profiles for aiding drug safety research and application.Drug-related deaths in hospital inpatients: A retrospective cohort study.Does Medical Expansion Improve Population Health?Barriers and facilitators to hospital pharmacists' engagement in medication safety activities: a qualitative study using the theoretical domains framework.Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis.Development and validation of a logic model for comprehensive medication management services.Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation.Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting.Predicting serious rare adverse reactions of novel chemicals.Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study.Pharmacomicrobiomics: a novel route towards personalized medicine?Type B adverse drug reactions reported by an immunoallergology department.Adverse Drug Reactions (ADR) and Emergencies.Adverse Drug Reactions, Power, Harm Reduction, Regulation and the ADRe ProfilesNurse-led medicines' monitoring in care homes study protocol: a process evaluation of the impact and sustainability of the adverse drug reaction (ADRe) profile for mental health medicines
P2860
Q28066096-CE163488-2977-45FF-9813-C0E7BD89BFC9Q28069555-4127E36D-4B30-493E-B418-B33739C02DFBQ28079380-7AD70161-BD93-4A4C-A8A8-4E5D10B28E5FQ28559384-B6FB7F41-B0D9-4B1C-9FA6-547EB6F2971BQ31154098-729227F6-9EC6-4D77-9CC5-983D13EB39CBQ36805116-33F073D4-53AA-41CE-AB03-DB4F315892D6Q38645302-EF207B8A-7AA2-4034-B71B-8B420CDF9EFEQ38904292-30FA77D1-BCD0-43EE-8226-04C4E2488523Q38996062-F56A9DA5-7D18-4B0B-929C-3C833AD65FDBQ39019169-2C5E78E4-6EFB-4DF2-ABE4-58C46D1C93BFQ39086689-820E73C0-A9FD-497D-B5F7-858FD26797D3Q39853016-C52EE7A4-5A39-4BC6-82AE-15E6F4E0464EQ39991967-717C4EF9-B5A8-41C4-B951-654D8A8DBFC6Q40124433-A5ED7DAF-A18C-439A-92F9-01BEAFB40AC5Q40461966-45E712BE-1261-4955-8146-4D623FBD3692Q40796795-F4AB4D15-96F0-41DB-9112-69684B3CA358Q45945293-AE7303BC-93F1-4444-968A-27D41B1620EBQ46801632-5EC59F19-EB7A-4864-8070-34EB8D769F35Q46847239-A9B0672E-C662-48A6-A18A-D29BE46291B3Q47114969-EAB8997F-EECC-4751-AF62-A3FBEFB5B9C6Q47128282-6D229FA3-681E-4414-941D-C9B86900EBABQ47156223-EEF46963-FE6E-4AB5-9998-352DD5CD8703Q47214402-C0409FB3-7F10-448B-8BA8-561EB1408D37Q47547273-74E098FE-C4D6-4D14-954E-7F46FE305AD4Q47550610-FA3639BF-B0DE-406B-8239-DCA90BB95A44Q47573647-9B2C9E1F-544F-40F8-B655-D24CFDD36EFAQ47653552-00A6FF8C-B078-415F-B3EF-628BA9782B70Q48130938-CE1272DF-12C5-4ADB-B181-9703318A59A3Q48261767-984CEB3A-B538-4CEB-A525-116182A12A7AQ49278505-F69BED41-DBB3-4719-97FA-DF30C182EFA5Q49889281-33C98BD7-470F-4295-8A8F-39A665CFF09AQ52607238-EBA3D9BC-E6BA-4FA1-B0B4-CA061F9C9C32Q54948520-25AAF52B-E75C-4F32-9D73-1B523FF24C8FQ55007103-9B45E6F6-03C1-4FD5-9B56-226D75888ACFQ55154583-EA03E692-D07B-436E-8E40-F91C9497497EQ55311475-1ECC3704-6FC2-431C-B6E8-6373A725D13BQ58722388-8A73961C-C69F-4DB4-A51C-962137DD6EEBQ59125704-C7BFED0D-4402-4CBE-819E-0FEBCB593B06
P2860
Epidemiology of adverse drug reactions in Europe: a review of recent observational studies
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Epidemiology of adverse drug r ...... f recent observational studies
@ast
Epidemiology of adverse drug r ...... f recent observational studies
@en
type
label
Epidemiology of adverse drug r ...... f recent observational studies
@ast
Epidemiology of adverse drug r ...... f recent observational studies
@en
prefLabel
Epidemiology of adverse drug r ...... f recent observational studies
@ast
Epidemiology of adverse drug r ...... f recent observational studies
@en
P2860
P1433
P1476
Epidemiology of adverse drug r ...... f recent observational studies
@en
P2093
Marc A Koopmanschap
P2860
P2888
P304
P356
10.1007/S40264-015-0281-0
P577
2015-05-01T00:00:00Z